You are not signed in. Sign In  
Pharmaceuticals and Fuels
  Todd Pray, Ph.D  
The Interplay between Human Health & Environmental Sustainability

Cost: $10
Click Here to Register

Many people do not consider producers of pharmaceuticals and producers of fuels and chemicals to be likely bedfellows, however, continual technological advances in R&D affirm that underneath the different policy issues and marketing strategies, product development and manufacturing platforms are very much aligned across the sectors. Ongoing and future collaboration between the two industries along these common approaches and goals can open up new training and mentorship possibilities for aspiring leaders in the Life Sciences. This lecture aims to frame and open discussion and debate around technology, markets, and policy drivers for both the pharmaceutical and the renewable fuel / chemical industries.
6 - 7 p.m. Registration & Networking
7 - 8 p.m. Seminar
8 - 8:30 p.m. Networking

Speaker Bio: Todd Pray, Ph.D., Program Head, Advanced Biofuels Process Demonstration Unit, Lawrence Berkeley National Laboratory.

Throughout his career and education, Todd has been committed to developing bioscience technologies that improve human health and environmental sustainability across a broad spectrum of sectors, including pharmaceutical, food science and renewable fuel and chemical product R&D. He is currently Program Head at the Advanced Biofuels and Bioproducts Process Demonstration Unit (ABPDU) at the Lawrence Berkeley National Laboratory. The ABPDU's mission is to partner with industry, other National Labs, and academia to develop and scale processes for biofuel, biochemical and other bioproduct technologies.

Prior to the ABPDU Todd spent a year at Impossible Food, Inc., a cutting-edge Bay Area start up in the emerging food biotech space, as Sr. Director of Product Development. Before his time there, Todd progressed through several roles at Amyris, Inc., most recently as Sr. Director of Product Management. Todd helped direct strategic collaborations for bio-based fuel and chemical product development and scale-up with the US Department of Energy and for Amyris’ commercial partnerships with Total New Energies and Beta Renewables. Before entering the renewable fuel and chemical industry Todd was a scientist and project leader at a number of Bay Area pharma/biotech companies such as Rigel, Exelixis and Acumen Pharmaceuticals. In this role he developed pre-clinical and clinical products in therapeutic indications as diverse as oncology, Hepatitis C virus, and Alzheimer’s disease.

After earning his BS in Biological Chemistry from the University of Chicago, Todd earned a Ph.D. in Biophysics from UCSF and received an MBA degree from the Haas School of Business at the University of California, Berkeley
Event Contact
Todd Slaby
Staff Liaison
Alexandra Schultz, AM'13


Event Information
Wednesday, Apr 29 2015 at 6:00pm - 8:30pm [ iCal ]
University of Chicago Offices
425 California Street Suite 1250
San Francisco, CA 94104